NEVARAPINE | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

NEVARAPINE
EDQM

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

Contact Supplier

pharmacompass-1-m-2026-04-20

As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

Contact Supplier

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

pharmacompass-2-m-2026-04-20

NEVARAPINE

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 18 USDMF, 11 CEP/COS, 1 JDMF, 4 EU WC, 8 NDC API, 8 Listed Suppliers

27 API Suppliers
18 USDMF
11 CEP/COS
1 JDMF
4 EU WC
8 NDC API
8 Listed Suppliers

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

166 FDF Dossiers, 58 FDA Orange Book, 62 Europe, 4 Canada, 2 Australia, 26 South Africa, 14 Listed Dossiers

166 FDF Dossiers
58 FDA Orange Book
62 Europe
4 Canada
2 Australia
26 South Africa
14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 100MG, TABLET, EXTENDED RELEASE;ORAL - 400MG, TABLET;ORAL - 150MG;200MG;300MG, TABLET;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 100MG
TABLET, EXTENDED RELEASE;ORAL - 400MG
TABLET;ORAL - 150MG;200MG;300MG
TABLET;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SUSPENSION;ORAL - 50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 6 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Panvo Organics, 1 Cerata Pharmaceuticals LLP, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 1 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 11 BASF, 10 Corel Pharma Chem, 7 DFE Pharma, 7 Gangwal Chemicals, 1 Gloria Interchem, 1 Huzhou Sunflower Pharmaceutical, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 23 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Fillers, Diluents & Binders, 37 Coating Systems & Additives, 31 Direct Compression, 27 Granulation, 26 Disintegrants & Superdisintegrants, 22 Lubricants & Glidants, 19 Controlled & Modified Release, 14 Thickeners and Stabilizers, 13 Co-Processed Excipients, 11 Solubilizers, 8 Chewable & Orodispersible Aids, 8 Film Formers & Plasticizers, 8 Taste Masking, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Parenteral, 3 Rheology Modifiers, 2 Coloring Agents

59 Fillers, Diluents & Binders
37 Coating Systems & Additives
31 Direct Compression
27 Granulation
26 Disintegrants & Superdisintegrants
22 Lubricants & Glidants
19 Controlled & Modified Release
14 Thickeners and Stabilizers
13 Co-Processed Excipients
11 Solubilizers
8 Chewable & Orodispersible Aids
8 Film Formers & Plasticizers
8 Taste Masking
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
4 Emulsifying Agents
3 Parenteral
3 Rheology Modifiers
2 Coloring Agents

DIGITAL CONTENT

11 News #PharmaBuzz

11 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 15 Regulatory FDF Prices

7 US Medicaid Prescriptions
15 Regulatory FDF Prices

MARKET PLACE

8 APIs, 6 FDF Dossiers

8 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 2 Health Canada Patents

1 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 Others

3 EDQM
2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

3 All

01 1Y0000520

02 1Y0000521

03 1Y0001499

filter CAS Number Reset all filters

3 All

01 2129618-40-2

02 1220988-26-1

filter Reference Standard Reset all filters

3 All

01 1Nevirapine (Anhydrous)

02 1Nevirapine for peak identification

03 1Nevirapine hemihydrate

Product Main Page

01

EDQM, Council of Europe

Nevirapine for peak identification

PEGS Boston Summit

Not Confirmed

01

EDQM, Council of Europe

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Nevirapine for peak identification

CAS Number : 129618-40-2

Quantity Per Vial : 0.058 mg

Sale Unit : 1

Order Code : Y0000521

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Nevirapine hemihydrate

PEGS Boston Summit

Not Confirmed

02

EDQM, Council of Europe

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Nevirapine hemihydrate

CAS Number : 220988-26-1

Quantity Per Vial : 15 mg

Sale Unit : 1

Order Code : Y0001499

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Nevirapine (Anhydrous)

PEGS Boston Summit

Not Confirmed

03

EDQM, Council of Europe

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Nevirapine (Anhydrous)

CAS Number : 129618-40-2

Quantity Per Vial : 30 mg

Sale Unit : 1

Order Code : Y0000520

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.